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RESEARCH ARTICLE
Association between a single nucleotide polymorphism in neuregulin-1 and
schizophrenia in Pakistani patients
Haider Ali Naqvi,1 Shafqat Huma,2 Hira Waseem,3 Kashaf Aqeel Zaidi,4 Hina Zuberi,5 Syed Hani Abidi6

Abstract
Objective: To determine the association of single-nucleotide polymorphism8nrg433E1006 in the neuregulin-1
gene associated with schizophrenia.
Methods: This case-control study was conducted at the Fountain House, Lahore, and the psychiatric clinics at the
Aga Khan University, Karachi, from 2010 to 2013.The total genomic deoxyribonucleic acid was isolated and singlenucleotide polymorphism8nrg433E1006 was screened by nested polymerase chain reaction followed by
sequencing. These sequences, from patients and controls, were aligned with the human neuregulin-1-glial growth
factor 2 gene sequence, which served as a reference sequence. The single nucleotide polymorphism genetic
algorithm was characterised at position 433 in the neuregulin-1 gene by aligning test and control sequences with
the neuregulin-1-glial growth factor 2reference sequence using ClustalW algorithm, implemented in the BioEdit
software.
Results: Of the 630 samples, 321(51%) were of cases and 309(49%)of controls. Moreover, 99(30.8%) cases and
79(25.6%) controls rendered correct neuregulin-1 gene frames. Of them, the single-nucleotide
polymorphism8nrg433E1006 was present in 62(62.6%) cases and 24(30.4%) controls. The analysis showed that the
odds ratio of having schizophrenia is 3.8 times higher in the presence of this single-nucleotide polymorphism at the
92 bp of neuregulin-1 gene with the 95% confidence interval(p=0.0001).
Conclusion: There was a strong association of single-nucleotide polymorphism8nrg433E1006 in the neuregulin-1
gene with schizophrenia.
Keywords: Schizophrenia, NRG-1 gene, SNP8nrg433E1006. (JPMA 68: 747; 2018)

Introduction
Schizophrenia is a mental disorder which runs a chronic
course leading to brain dysfunction and the deterioration
of personality.1 It affects one individual out of a hundred.
Heritability and genetic risk is postulated to play a major
role in the aetiology of schizophrenia.2 The completion of
the human genome project has allowed us to understand
the molecular basis of a number of human diseases.
Research pertaining to genetics of schizophrenia has also
progressed rapidly over the past decade. High
throughput mapping and scanning of the human
genome by emerging technologies has enabled us to
identify disease-specific gene mutations quickly. Genetic
mapping follows the descent down the generations of
deoxyribonucleic acid (DNA) markers in pedigree and
their segregation with illness. Either a very large single
pedigree or a collection of smaller families where the
effects of linkage is additive is studied. The rates of
schizophrenia were greater among the biological
1,4Department of Psychiatry, Ziauddin University, Karachi, 2University College

of Medicine & Dentistry, University of Lahore, 3,5,6Department of Biological and
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relatives of the schizophrenic adoptees than among the
relatives of controls; a finding that supports the genetic
hypothesis. Furthermore, the rate of schizophrenia was
not increased among couples that adopted the
schizophrenic adoptees, suggesting that environmental
factors were not of substantial importance.
Neuregulin-1 (NRG-1) is a gene that has shown perhaps
one of the most robust linkages in terms of disease
causation.3 NRG-1 is located on chromosome 8p and is a
large gene of about 1.2 Mbp, with at least 30 exons and
nine potential promoters. Chromosome 8 has been one of
the more problematic chromosomes in terms of sequence
assembly and marker orders, with further complications
arising due to inversion polymorphisms4 and deletions.5
This may, in part, explain the differences in the intervals
reported. Alternatively, there may be a second
schizophrenia gene on chromosome 8p. A core haplotype
(HAP ice) was identified by Stefansson et al. in the original
study on the Icelandic population that first implicated this
gene. Recently, the same region was identified in the Irish,
Scottish and Chinese populations. NRG-1 is a plausible
susceptibility gene as it plays a direct role in the expression
of the N-methyl-D-aspartate (NMDA) receptor by
regulating of glutamate and the neurotransmitters. The
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current study was planned to determine if single
nucleotide polymorphism in the NRG-1 has an association
with schizophrenia. To the best of our knowledge, no
previous study has explored the association of NRG-1
mutation with schizophrenia in a Pakistani population.
Unravelling the genetic risk associated with schizophrenia
has the potential to stimulate further research in the area
of drug-designing to treat this serious mental disorder.

Patients and Methods
This case-control study was conducted at the Fountain
House, Lahore, and the psychiatric clinics at the Aga Khan
University, Karachi, from 2010 to 2013. The sample size
required for this study was estimated based on the
prevalence of exposure to risk factors among controls (%),
and the number of cases required to detect a relative risk
(RR) of 1.5. In an earlier study exploring the same issue (a
five-markerhaplotype) in Han Chinese population, the risk
was estimated to be 27% among the controls and 37% in
cases.6 The sample size was calculated using the following
formula:
N = (Z1-a/2 + Z1-b)2 (p1(1 - p1) + p2(1 - p2))/ (p1 - p2)2
The proportion in the control group was taken as null
hypothesis while the proportion in cases was taken as the
alternative hypothesis.7 In the above equation, p1
representeds group one and p2 represented group 2. With
the power of 80%, and significance level of 5%, the
minimum estimated sample size was 300 cases and 300
controls.
Based on the afore-mentioned calculations, patients with
the clinical diagnosis for schizophrenia, as per the 10th
revision of the International Statistical Classification of
Diseases and Related Health Problems(ICD 10),8 were
included in the study. The individuals with comorbid
substance use disorder, mental retardation, mood
disorder, head injury and schizoaffective disorder were
excluded. Sampling was carried out on patients whose
relatives gave consent. The patients were assessed for
clinical remission, social and occupational functioning.
Details of socio-demographic variables were collected on
a predesigned proforma. All controls and cases consented
to participate in the study. Information on the educational
status, marital status, occupation, family history of
psychiatric disorder, birth order was collected. First
degree relatives were enrolled as controls.
Then, 5ml blood was collected from the enrolled patients
and the controls. DNA extracted from the blood samples
was performed using a genomic DNA isolation kit
(Qiagen) as given in the manufacturer's protocol. The
isolated DNA was stored at -20 degrees Celsius.
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DNA isolated from the blood samples of cases and controls
was used to amplify single-nucleotide polymorphism
(SNP) 8nrg433E1006 through polymerase chain reaction
(PCR), which lies in the 5' exon of intravenous glial growth
factor 2 (GGF2), using nested PCR strategy, followed by
sequencing. The first round was performed using primers
CCTACCCCTGCACCCCCTAAATAA
and
CTTCCTGTCGACTGCCCCCTGCT. In the first round, 30ng of
genomic DNA was amplified in the presence of 3.5pmol of
each primer, 0.25U Taq polymerase, 0.2mM
deoxynucleotide triphosphates (dNTPs), 10% dimethyl
sulfoxide (DMSO), 1% glycerol and 2.5mM magnesium
chloride (MgCl). Cycling conditions for the first round
were: 95°C for 10 minutes, followed by 40 cycles of 94°C for
15 seconds, annealing at 63°C for 30 seconds, and
extension at 72°C for 1 minute. The second round was
performed using the same concentration of inner primers,
TGCCACTACTGCTGCTGCT
and
ACCTTTCCCTCGATCACCAC. Except for the addition of 3ul
of the first amplification reaction, as a template, to 27ul of
the mixture, conditions were the same as in the first
amplification reaction. Cycling conditions for the second
amplification were 95°C for 10 minutes, followed by 35
cycles at 94°C for 15 seconds, annealing at 58°C for 30
seconds, and extension at 72°C for 1 minute. The 163 bp
PCR product was sent for sequencing to Macrogen with
inner forward primer.
The NRG1 gene sequences from patients and controls
were aligned with human NRG1-GGF2 gene sequence
(accession number NM_013962.2), which served as a
reference sequence. The SNP (G/A) was characterised at
position 433 in NRG1 gene. The position 433, after
aligning the NRG1-GGF2 gene, corresponded to position
92 in the alignment. We used NRG1-GGF2 sequence
(position 92 in alignments) to locate SNP in the test and
control groups. The test and control sequences were
aligned with NRG1-GGF2 sequence using ClustalW
algorithm implemented in the BioEdit software, and SNPs
at position 92, in the respective test and control
sequences were identified, using position 92 of the NRG1GGF2 gene as reference. The statistical association
between SNP(s) in NRG-1 with cases and controls was
assessed by calculating odds ratio. The study was given
ethical approval by the institutional ethics review
committee and was done in compliance with ethical
standards highlighted in the Declaration of Helsinki.

Results
Of the 630 samples, 321(51%) were of cases and 309(49%)
of controls. Overall, 261(41.4%) cases and 252(40%)
controls were recruited from the Lahore centre and
60(9.5%) cases and 57(9%) controls from the Karachi
J Pak Med Assoc
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Table-1: Socio-demographic Characteristics: The socio-demographic characteristics of
both cases and controls are shown.
Variables

Age (In Years)
< 10
20-Nov
21-30
31-40
41-50
51-60
61-70
Gender
Male
Female
Education
Illiterate
Primary
Secondary
Intermediate
Graduate
Postgraduate
Marital Status
Single
Married
Divorced
Widowed/er
Separated
Occupation
Unemployed
Businessmen
Housewife
Professional
Skilled labourer
Unskilled labourer
Students
Others
Religion
Islam
Christian
Hindu
Family History of Mental Health
Yes
No
Don’t know
Past Contact
Psychiatrist
General practitioner
Hakim
Faith healer
Other
No Psychiatric visit
Not answer
Family History of Schizophrenia
Yes
No

Vol. 68, No. 5, May 2018

Cases
N=321(%)

Controls
N=305(%)

6(1.9)
62(19.4)
138(43.1)
87(27.2)
24(7.5)
3(0.9)

14(4.6)
119(39)
95(31.1)
55(18.0)
17(5.6)
5(1.6)

192(59.8)
129(40.2)

238(78.5)
65(21.5)

32(10)
60(18.8)
117(36.7)
70(21.9)
32(10)
8(2.5)

20(6.6)
55(18.1)
72(23.7)
95(31.3)
47(15.5)
15(4.9)

223(69.5)
44(13.7)
39(12.1)
1(0.3)
14(4.4)

76(24.9)
225(73.8)
1(0.3)
3(1.0)
-

267(83.4)
5(1.6)
8(2.5)
13(4.1)
8(2.5)
1(0.3)
15(4.7)
3(1.0)

1(0.3)
11(3.6)
13(4.3)
50(16.4)
120(39.5)
89(29.3)
14(4.6)
6(1.8)

319(99.4)
1(0.3)
1(0.3)

259(84.9)
43(14.1)
3(1.0)

154(48.1)
81(25.3)
85(26.6)

3(1.0)

164(51.6)
97(30.5)
21(6.6)
33(10.4)
3(0.9)
-

1(0.3)
49(16.5)
253(82.9)

103(32.2)
16(5.2)
89(27.8)
33(10.1)
Contd. next column >>>>

Don’t know
Birth Order
1st
2nd
3rd
4th
5th
6th
7th
8th
10th
11th
Don’t know

128(40.0)
-

3(1.0)
253(82.9)

40(12.5)
90(28.1)
75(23.4)
41(12.8)
25(7.8)
9(2.8)
3(0.9)
37(11.6)

13(28.9)
9(20)
7(15.6)
8(17.8)
2(4.4)
3(6.7)
1(2.2)
1(2.2)
1(2.2)
-

Table-2: The frequency of SNP SNP8nrg433E1006in NRG-1 gene in cases and control:
The single SNP G/A was characterised at position 433 in NRG1 gene. The position 433,
after aligning the NRG1-GGF2 gene reference sequence, corresponded to position 92 in
the alignment.
Guanine (%) Adenine (%) Thymine (%) Cytosine (%) Total (%)
Samples
(n=99)
Controls
(n=79)

62(62%)

53(53%)

2(2%)

2(%)

99

24(30%)

23(30%)

14(17)

9(12%)

79

SNP: Single-nucleotide polymorphism
NRG1: Neuregulin-1
G/A: Genetic algorithm
GGF2: Glial growth factor 2.

centre. Thus, an ethnically diverse sample was recruited as
planned. Moreover, there were 418(66.3%) males
(181(43%) cases; 237(57%) controls) and 212(33.7%)
females (140(66%) cases; 72(34%) controls). Besides,
117(36.4%) cases and 72(23.3%) controls had secondary
school education; 44(13.7%) cases and 225(72.8%)
controls were married; and 267(83%) cases were
unemployed and dependent on family/others for source
of financial support. Family history of definite mental
illness was reported in 154(48%) cases, while family history
of schizophrenia was reported in 103(32%) cases (Table-1).
The total genomic DNA was isolated and
SNP8nrg433E1006 was screened by nested PCR followed
by sequencing. It was found that 99(30.8%) and 79(25.6%)
sequences from cases and controls, respectively, showed
correct NRG1 gene frames (Table-2).
Of them, the nucleotide G was present in 62(62.6%)
sequences from cases, while it was present in 24(30.4%)
sequences from subject group. The analysis showed that
the odds ratio (OR) of having schizophrenia is 3.84 times
higher in the presence of this SNP at the 92 bp of NRG-1
gene with the 95% confidence interval (CI), 2.0471 to
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Table-3: Odds ratio of SNP at NRG-1 mutation between cases and controls. Odds ratio
was found to be 3.84, 95% C.I, 2.0471 to 7.2033, P-value < 0.0001.

Cases
Controls

Guanine Nucleotide

Non-guanine Nucleotide

Total

62(62%)
24 (30%)
86

57 (55%)
46 (59%)
103

119
70
189

SNP: Single-nucleotide polymorphism
NRG1: Neuregulin-1.

7.2033, and highly significant difference (p=0.0001)
(Table-3).
We used NRG1-GGF2 sequence (position 92 in
alignments) to locate SNP in the test and control groups.

The SNP was identified to be located at the 92ndbp of the
163bp-long amplified product (Figure).

Discussion
The NRG1gene is identified as a susceptibility gene for
schizophrenia by using association methodologies based
on microsatellite markers, detecting SNPs. In the present
case-control study, we investigated the frequency of atrisk gene markers in a Pakistani population. One of the
roles that NRG1 plays in the adult central nervous system
(CNS) is the expression and phosphorylation of certain
neurotransmitter-receptor subunits, in certain neurons
and their related complexes, in an activity dependent
manner.9-12 NRG1 does not appear to be restricted to a
single neurotransmitter system; rather, it appears to play a
role in NMDA and acetylcholine,
as well as g-amino butyric acidreceptor, at least in certain
neuronal systems, the prime
function of this is to regulate the
composition of neurotransmitter
receptors in maturing synapses
in the brain.9,11-13

GGF2: Glial growth factor 2

Figure: NRG-1 Gene Sequence alignment: The Neuregulin 1 (NRG1) gene sequences from patients and controls were aligned with
Human NRG1-GGF2 gene sequence (Accession number NM_013962.2), which served as a reference sequence. The singlenucleotide polymorphism (SNP) G/A has been characterized at position 433 in NRG1 gene. The position 433, after aligning the
NRG1-GGF2 gene, corresponded to position 92 in our alignment (Black arrow), and the same position was used to detect the SNP
in the respective test and control sequences.

With the completion of the
Human Genome Project in April
2003, public gene databases
have led to genome wide
association studies that have
identified many candidate
genes. However, these findings
have
not
always
been
replicated in different studies
and
merely
signify
an
association with schizophrenia.
Two recent meta-analyses have
supported possible linkage at
1q, 2q, 3p, 5q, 6p, 8p, 11q, 13q,
14p, 20q and 22q. Genes such
as NRG1 and catechol Omethyltransferase (COMT) have
been identified as candidates
for causing schizophrenia.
Epigenetic influences such as
increased methylation on
dopamine receptor D2 (DRD2)
gene in normal individuals has
also been proposed which is
not found in monozygotic twin
with schizophrenia. Other
genes proposed in 2005 by
Harrison and Weinberger
included G72, D-amino acid
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oxidase (DAO), regulator of G-protein signalling 4 (RGS4),
proline dehydrogenase (PRODH), mGluR3, disrupted in
schizophrenia 1 (DISC1), COMT, NRG1 and dystrobrevinbinding protein 1(dysbindin, or DTNBP1).
COMT is the most plausible of the susceptibility genes.
Located on chromosome 22q11, it codes for the postsynaptic intracellular enzyme COMT, which is involved in
the methylation and degradation of the catecholamine
neurotransmitters dopamine, epinephrine, and
norepinephrine. The gene has multiple variants that have
an effect on its activity. A variant with the valinemethionine configuration is known to have a protective
effect against schizophrenia as compared to the valinevaline variant which has a greater dopamine degradation
effect.
Another gene that codes for the nitric oxide synthase 1
adaptor protein (NOS1AP) is found in high concentration
in inhibitory neurons in the brain. Nitric oxide regulates
intracellular enzyme activities and hence works as a
messenger. Using a recently developed statistical
technique of linkage disequilibrium, researchers have
succeeded in identifying a single-nucleotide
polymorphism (SNP) associated with increased levels of
expression of this gene in post-mortem brain samples
from patients with schizophrenia.
Another gene associated with schizophrenia is RELN,
which codes for the protein reelin that is involved in the
regulation of brain development and GABAergic activity.
In an international study, a common variant in this gene
increased the risk of developing schizophrenia, but only
in the female population.
Numerous studies have also found evidence linking
abnormalities in neurodevelopmental genes with an
increased susceptibility to schizophrenia. Genes such as
DISC1, NRG1and DTNBP1 have been associated with
schizophrenia in a number of studies, but with a
variability of results. Such findings are also indicative of
the hypothesis that multiple genetic variations may result
in a common clinical outcome in the case of
schizophrenia. A case-control study conducted through
the collaborative efforts of researchers from University of
North Carolina School of Medicine, the Karolinska
Institute in Sweden, the Stanley Centre for Psychiatric
Research at the Broad Institute of MIT and Harvard, and
the Mt. Sinai School of Medicine in New York published in
2013 concluded that two genetically determined
processes were of particular importance to schizophrenia,
the calcium channel pathway and the micro-ribonucleic
acid (micro-RNA) 137 pathway.
Vol. 68, No. 5, May 2018
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The identification of numerous susceptible genes
establishes the basis of having a first-degree relative with
schizophrenia being a major risk factor for developing the
disorder. Since the genetic make-up of twins is almost
identical, the expected prevalence in susceptible pairs
amongst them would be high. Studies have reported a
higher concordance rate amongst monozygotic twins
(MZ) (43%) as compared to dizygotic twins (22%).14 The
indistinguishable genetic basis of MZ twins explains the
association. However, there is substantial discordance
within the monozygotic pairs which highlights the
importance of non-genetic factors. In accordance with the
two-hit hypothesis of schizophrenia, a combination of
genetic susceptibility combined with a distinct
developmental insult can ultimately lead to the
occurrence of a full clinical syndrome.15 Proposed
mechanisms for discordance amongst MZ twins are
environmental factors and other epigenetic processes
which regulate gene expression via DNA, histone proteins
and chromatin modifications. Furthermore, significant
differences in DNA methylation of peripheral tissue
samples between MZ twins explain the basis of
phenotypic variations amongst them. The differentially
methylated positions, cg23933044, located in the
promoter regulatory region of C5ORF42, revealed that
affected twin had reduced DNA methylation as opposed
to their unaffected co-twin.16 Thus, significant
associations can be formed between MZ twins and
schizophrenia based on genetic, epigenetic and
environmental factors.
Despite investment of many years of research, the
aetiology of schizophrenia has yet to be unravelled. The
methods used for mapping susceptibility genes,
including genome-wide association studies (GWAS) and
copy number variation (CNV) studies, have progressed
over the years. Even so, some patients with schizophrenia
have no known family history of the disorder and this may
be the result of new mutations. Support for this
phenomenon lies in the observation that de novo
mutations are more common in patients with
schizophrenia as compared to the normal population.
The major strengths of this study were that it was carried
out on a large number of subjects from two different cities
of Pakistan. Additionally, by employing sequencing
strategy, we were able to carry out in-depth genetic
analysis of NRG-1 gene, which would not have been
possible by simple visualisation of SNP-specific band on
agarose gel. The limitations are that although our sample
was derived from genetically diverse population in
Karachi and Lahore, this cannot be assumed to be
representative of the population at large.
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Conclusion
An SNP was identified to be located at the 92ndbp of the
163bp-long amplified product. Future studies exploring
similar associations, stratified at various sites, would add
further evidence to the body of literature in this important
public health concern.
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